A. All patient who received LEN for more than 3 months (N = 38) | Â | ||
---|---|---|---|
 | Normal cytogenetic group | Abnormal cytogenetic group | p value |
Categorized by MC only | 64% | 33% | 0.07 |
Categorized by MC/FISH/SNP-A | 64% | 54% | 0.4 |
B. Monotherapy (LEN only) patients (N = 27) | Â | Â | |
 | Normal cytogenetic group | Abnormal cytogenetic group | p value |
Categorized by MC | 60% | 17% | 0.08 |
only | Â | Â | Â |
Categorized by MC/FISH/SNP-A | 64% | 44% | 0.27 |
C. Patients with combination therapy of AZA + LEN (N = 11) | Â | ||
 | Normal cytogenetic group | Abnormal cytogenetic group | p value |
Categorized by MC only | 75% | 67% | 0.85 |
Categorized by MC/FISH/SNP-A | 67% | 75% | 0.85 |